Millennium Management
PYXS icon

Millennium Management’s Pyxis Oncology PYXS Stock Holding History

Millennium Management’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-47,600
Closed -$175K – 6367
2024
Q3 		$175K Buy
+47,600
New +$167K ﹤0.01% 5482
2024
Q2 		– Sell
-42,400
Closed -$181K – 6404
2024
Q1 		$181K Buy
+42,400
New +$178K ﹤0.01% 5409

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management's PYXS Position: Q1 2026 in Review

Millennium Management reduced its Pyxis Oncology (PYXS) stake by 46% in Q1 2026, selling an estimated $521K and leaving 397,625 shares worth $581K. The position accounts for ﹤0.01% of the portfolio, ranked #4685.

Millennium Management first reported a position in PYXS in Q4 2021 and has held it in 15 quarters since. The position peaked at $7M in Q3 2024. 78 funds tracked by Wall St. Rank hold PYXS as of Q1 2026.

  • Millennium Management held 397,625 shares of Pyxis Oncology worth $581K as of Q1 2026.
  • Millennium Management sold 345,482 Pyxis Oncology shares in Q1 2026, an estimated $521K.
  • Pyxis Oncology made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4685 holding.
  • Millennium Management first reported a position in Pyxis Oncology in Q4 2021 and has held it in 15 quarters since.
  • Millennium Management's Pyxis Oncology position peaked at $7M in Q3 2024.
  • 78 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.